No prior CDK4/6i and AKT pathway altered26 11.0 mo CAPItello-291 Unmet Needs in Second-Line Therapy for ER-Positive, HER2-Negative Advanced Breast Cancer
An Update on Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis Abstract Medication-related osteonecrosis of the jaw (MRONJ) is a feared complication of
EMJ GOLD - European Medical Journal
The GOLD team believes that a strong relationship between pharma and healthcare professionals delivers the best patient outcomes.
Oncology - European Medical Journal
We present the latest EMJ Oncology eJournals, including abstract summaries, insightful interviews, and breaking news in the field of oncology.
EMJ | Elevating the quality of healthcare globally
In this episode, Jonathan Sackier sits down with Tom Bradshaw to explore the rapidly evolving landscape of digital health. They discuss Bradshaw’s expertise in the clinical application of AI and digital technologies, his work with the NHS and private sector firms, and more.
Reproductive Health - European Medical Journal
In this episode, Jonathan is once again joined by Vikram Talaulikar, Associate Specialist in reproductive medicine at the University College London Hospitals (UCLH) NHS Foundation Trust, UK, to explore different treatment options for menopause, including lifestyle changes, alternative medicine, hormone replacement therapy, and non-hormonal treatments.
Nephrology - European Medical Journal
We present the latest EMJ Nephrology eJournals, the only eJournal to provide nephrologists with peer-reviewed articles, congress reviews...
Dermatology - European Medical Journal
We present the latest EMJ Dermatology eJournals, including abstract summaries, insightful interviews, and breaking news in this field.
New CML Treatment Shows Promise, But Standard Therapy Endures
Oct 18, 2024 · The ASC4FIRST trial has shown asciminib, a novel BCR::ABL1 inhibitor, as a promising alternative to current tyrosine kinase inhibitors (TKIs) for chronic phase (CP) chronic myeloid leukaemia (CML). However, experts caution that the study’s design and outcomes raise significant questions, suggesting that imatinib, the original …
Microbiology & Infectious Diseases - European Medical Journal
Featuring the latest EMJ Microbiology & Infectious Diseases journals, alongside articles that include up-to-date research and news in the field.